rxstat › Shortages › Moxifloxacin

Moxifloxacin (Avelox, Vigamox) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Oct 16, 2026

Some Moxifloxacin products are in shortage in Canada (7 of 19 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 22, 2027.

A fluoroquinolone antibiotic used to treat bacterial infections such as pneumonia, sinus and eye infections.

Products affected
7 / 19
In shortage since
Nov 30, 2020
Est. full return
Jan 22, 2027
Reports on file
65
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-MOXIFLOXACIN
0.5% · SOLUTION · APOTEX INC
DIN 02406373 · since Dec 2, 2025, est. end Jan 22, 2027 · Disruption of the manufacture of the drug.
Active shortage
PMS-MOXIFLOXACIN
0.5% · SOLUTION · PHARMASCIENCE INC
DIN 02432218 · since Oct 4, 2026, est. end Dec 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
MOXIFLOXACIN
0.5% · SOLUTION · SANIS HEALTH INC
DIN 02529076 · since Aug 5, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-MOXIFLOXACIN
400MG · TABLET · TEVA CANADA LIMITED
DIN 02375702 · since Jun 8, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-MOXIFLOXACIN
0.5% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02472120 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-MOXIFLOXACIN
400MG · TABLET TABLET · APOTEX INC
DIN 02404923 · since Mar 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
BIO-MOXIFLOXACIN
400MG · TABLET · BIOMED PHARMA
DIN 02447266 · since Nov 30, 2020, no end estimate · Delay in shipping of the drug.
Discontinued
MOXIFLOXACIN INJECTION
400MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02433087
Resolved
MOXIFLOXACIN INJECTION
400MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02433087 · ended Jul 30, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ MOXIFLOXACIN
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02411520 · ended Jul 27, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ MOXIFLOXACIN
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02411520 · ended Apr 27, 2026 · Demand increase for the drug.
Resolved
SANDOZ MOXIFLOXACIN
400MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02383381 · ended Apr 6, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Moxifloxacin is currently affected by 7 active shortage reports filed with Health Canada by APOTEX INC, PHARMASCIENCE INC, SANIS HEALTH INC, TEVA CANADA LIMITED and 2 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Moxifloxacin is classified under “ANTIINFECTIVES” (ATC S01AE).

Recent changes

Common questions

What is Moxifloxacin used for?

A fluoroquinolone antibiotic used to treat bacterial infections such as pneumonia, sinus and eye infections.

When will Moxifloxacin be back in stock in Canada?

The latest manufacturer estimate is Jan 22, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Moxifloxacin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiinfectives)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Trimethoprim Polymyxin B No current shortage Erythromycin (Eryc Delayed-Release) Partial shortage 2 of 17 reported products affected · est. return Dec 14, 2026 Gatifloxacin (Zymar) Partial shortage 1 of 3 reported products affected · est. return Nov 20, 2026 Ofloxacin (Ocuflox) Partial shortage 1 of 2 reported products affected · est. return Nov 30, 2026 Polymyxin B Gramicidin Neomycin Partial shortage 1 of 1 reported products affected Sulfacetamide Partial shortage 1 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.